type-2-diabetes-mellitus

Documents about type-2-diabetes-mellitus

• A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together#245420ClinicalTrials.gov
• Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformin in People With Type 2 Diabetes Inadequately Controlled With Metformin#249576ClinicalTrials.gov
• INVESTIGATING NEW DIMENSIONS OF MEDICATION NONADHERENCE AMONG PEOPLE WITH TYPE 2 DIABETES TO INFORM THE DEVELOPMENT OF FUTURE TARGETED INTERVENTIONS#264979ScholarBank@NUS
• A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects#67786ClinicalTrials.gov
• Role of Fasted Exercise on Improving Cardiometabolic Health#126011ClinicalTrials.gov
• Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)#127844ClinicalTrials.gov
• Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)#136278ClinicalTrials.gov
• Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users#136284ClinicalTrials.gov
• Ghrelin and Diastolic Heart Function#148689ClinicalTrials.gov
• Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR)#154892ClinicalTrials.gov
• Renohemodynamic Effects of Combined empagliflOzin and LosARtan#160332ClinicalTrials.gov
• Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients#181732ClinicalTrials.gov
• Comparison of Progressive Muscle Relaxation and Stretching Exercises in Diabetic Population#184765ClinicalTrials.gov
• Proteomic signatures of early retinal neurodegeneration in type 2 diabetes mellitus.#255231NCBI PubMed Central
• Sitagliptin in Combination With Metformin and Sulfonylurea#256848ClinicalTrials.gov
• The Role of ONECUT1 Variants in Monogenic and Type 2 Diabetes Mellitus#276059PubMed Central
• Study About Effect of Saxagliptin on Circulating Endothelial Progenitor Cells and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients#126061ClinicalTrials.gov
• Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients#160295ClinicalTrials.gov
• A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs)#230363ClinicalTrials.gov
• Literature Review: Efektivitas Konseling Farmasi Terhadap Kepatuhan Minum Obat pada Pasien Diabetes Melitus Tipe 2: Literature Review: Effectiveness of Pharmacist Counseling on Compliance with Taking Medication in Diabetes Mellitus Type 2 Patients#268834Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya
• Literature Review: Efektivitas Konseling Farmasi Terhadap Kepatuhan Minum Obat pada Pasien Diabetes Melitus Tipe 2: Literature Review: Effectiveness of Pharmacist Counseling on Compliance with Taking Medication in Diabetes Mellitus Type 2 Patients#268940Jurnal Surya Medika (JSM)
• Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver#148676ClinicalTrials.gov
• A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients#67837ClinicalTrials.gov
• Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial#143762ClinicalTrials.gov
• A Research Study Looking at Long-term Blood Sugar Control in People With Type 2 Diabetes Being Treated With Xultophy® in a Real-world Setting in Italy#146372ClinicalTrials.gov
• Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering Drugs#158173ClinicalTrials.gov
• A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes#162427ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)#226209ClinicalTrials.gov
• Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver Disease#146421ClinicalTrials.gov
• Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes Mellitus#148717ClinicalTrials.gov
• Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin#162425ClinicalTrials.gov
• Exploring the Effectiveness of AI Generative Models for Diabetic Patients#226161ClinicalTrials.gov
• A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics#136213ClinicalTrials.gov
• Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients#143749ClinicalTrials.gov
• Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD#172531ClinicalTrials.gov
• Characterization and Mechanism Research of the Pre-disease State of Obese Type 2 Diabetes Mellitus#226180ClinicalTrials.gov
• Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance#6909OpenAlex
• Effectiveness of Dapagliflozin for Weight Loss#18536ClinicalTrials.gov
• Bioenergetics and Metabolism in Pediatric Populations#126096ClinicalTrials.gov
• The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients#140947ClinicalTrials.gov
• Screening, Brief Intervention, and Referral to Treatment in Primary Care#141194ClinicalTrials.gov
• Physiologic Insulin Therapy for the Management of Hyperglycemia in the Hospital#141199ClinicalTrials.gov
• Molecular Mechanisms and Carotid Atherosclerosis#143778ClinicalTrials.gov
• Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects#146357ClinicalTrials.gov
• Detecting chromatin state alterations in PBMCs associated with Type 2 Diabetes Mellitus.#159901NCBI PubMed Central
• Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina#162400ClinicalTrials.gov
• CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)#162418ClinicalTrials.gov
• Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas#208399ClinicalTrials.gov
• Role of Metformin in Posterior Capsule Opacification#208410ClinicalTrials.gov
• Corazon de la Familia (Heart of the Family)#217169ClinicalTrials.gov